178 related articles for article (PubMed ID: 11920650)
1. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.
Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E
Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650
[TBL] [Abstract][Full Text] [Related]
2. Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients.
Katballe N; Christensen M; Wikman FP; Ørntoft TF; Laurberg S
Gut; 2002 Jan; 50(1):43-51. PubMed ID: 11772966
[TBL] [Abstract][Full Text] [Related]
3. Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome.
Schneider NB; Pastor T; Paula AE; Achatz MI; Santos ÂRD; Vianna FSL; Rosset C; Pinheiro M; Ashton-Prolla P; Moreira MÂM; Palmero EI;
Cancer Med; 2018 May; 7(5):2078-2088. PubMed ID: 29575718
[TBL] [Abstract][Full Text] [Related]
4. MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population.
Chan TL; Chan YW; Ho JW; Chan C; Chan AS; Chan E; Lam PW; Tse CW; Lee KC; Lau CW; Gwi E; Leung SY; Yuen ST
Am J Hum Genet; 2004 May; 74(5):1035-42. PubMed ID: 15042510
[TBL] [Abstract][Full Text] [Related]
5. Novel MLH1 frameshift mutation in an extended hereditary nonpolyposis colorectal cancer family.
Kadiyska TK; Kaneva RP; Nedin DG; Alexandrova AB; Gegova AT; Lalchev SG; Christova T; Mitev VI; Horst J; Bogdanova N; Kremensky IM
World J Gastroenterol; 2006 Dec; 12(48):7848-51. PubMed ID: 17203532
[TBL] [Abstract][Full Text] [Related]
6. Rare single-nucleotide variants of MLH1 and MSH2 genes in patients with Lynch syndrome.
Mirabdolhosseini SM; Yaghoob Taleghani M; Rejali L; Sadeghi H; Fatemi N; Tavallaei M; Famil Meyari A; Saeidi N; Ketabi Moghadam P; Sadeghi A; Asadzadeh Aghdaei H; Zali MR; Nazemalhosseini Mojarad E
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1930. PubMed ID: 37919876
[TBL] [Abstract][Full Text] [Related]
7. [Lynch syndrome: case report and review of the literature].
Bouguenouch L; Samri I; Belhassan K; Sayel H; Abbassi M; Bennis S; Benajah DA; Ibrahimi A; Amarti A; Ouldim K
Pan Afr Med J; 2016; 24():142. PubMed ID: 27642480
[TBL] [Abstract][Full Text] [Related]
8. Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.
Varley JM; McGown G; Thorncroft M; James LA; Margison GP; Forster G; Evans DG; Harris M; Kelsey AM; Birch JM
Am J Hum Genet; 1999 Oct; 65(4):995-1006. PubMed ID: 10486318
[TBL] [Abstract][Full Text] [Related]
9. A 39 kb structural variant causing Lynch Syndrome detected by optical genome mapping and nanopore sequencing.
Bjørnstad PM; Aaløkken R; Åsheim J; Sundaram AYM; Felde CN; Østby GH; Dalland M; Sjursen W; Carrizosa C; Vigeland MD; Sorte HS; Sheng Y; Ariansen SL; Grindedal EM; Gilfillan GD
Eur J Hum Genet; 2024 May; 32(5):513-520. PubMed ID: 38030917
[TBL] [Abstract][Full Text] [Related]
10. Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome.
Lindor NM
Surg Oncol Clin N Am; 2009 Oct; 18(4):637-45. PubMed ID: 19793571
[TBL] [Abstract][Full Text] [Related]
11. Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes.
DeRycke MS; Gunawardena S; Balcom JR; Pickart AM; Waltman LA; French AJ; McDonnell S; Riska SM; Fogarty ZC; Larson MC; Middha S; Eckloff BW; Asmann YW; Ferber MJ; Haile RW; Gallinger S; Clendenning M; Rosty C; Win AK; Buchanan DD; Hopper JL; Newcomb PA; Le Marchand L; Goode EL; Lindor NM; Thibodeau SN
Mol Genet Genomic Med; 2017 Sep; 5(5):553-569. PubMed ID: 28944238
[TBL] [Abstract][Full Text] [Related]
12. Variation in genome-wide mutation rates within and between human families.
Conrad DF; Keebler JE; DePristo MA; Lindsay SJ; Zhang Y; Casals F; Idaghdour Y; Hartl CL; Torroja C; Garimella KV; Zilversmit M; Cartwright R; Rouleau GA; Daly M; Stone EA; Hurles ME; Awadalla P;
Nat Genet; 2011 Jun; 43(7):712-4. PubMed ID: 21666693
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
14. Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer.
Barnetson RA; Cartwright N; van Vliet A; Haq N; Drew K; Farrington S; Williams N; Warner J; Campbell H; Porteous ME; Dunlop MG
Hum Mutat; 2008 Mar; 29(3):367-74. PubMed ID: 18033691
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
[TBL] [Abstract][Full Text] [Related]
16. A yeast two-hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ-line mutations.
Kondo E; Suzuki H; Horii A; Fukushige S
Cancer Res; 2003 Jun; 63(12):3302-8. PubMed ID: 12810663
[TBL] [Abstract][Full Text] [Related]
17. Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants.
Borràs E; Pineda M; Cadiñanos J; Del Valle J; Brieger A; Hinrichsen I; Cabanillas R; Navarro M; Brunet J; Sanjuan X; Musulen E; van der Klift H; Lázaro C; Plotz G; Blanco I; Capellá G
J Med Genet; 2013 Aug; 50(8):552-63. PubMed ID: 23709753
[TBL] [Abstract][Full Text] [Related]
18. Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions.
Thompson BA; Greenblatt MS; Vallee MP; Herkert JC; Tessereau C; Young EL; Adzhubey IA; Li B; Bell R; Feng B; Mooney SD; Radivojac P; Sunyaev SR; Frebourg T; Hofstra RM; Sijmons RH; Boucher K; Thomas A; Goldgar DE; Spurdle AB; Tavtigian SV
Hum Mutat; 2013 Jan; 34(1):255-65. PubMed ID: 22949387
[TBL] [Abstract][Full Text] [Related]
19. A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry.
Thompson BA; Goldgar DE; Paterson C; Clendenning M; Walters R; Arnold S; Parsons MT; Michael D W; Gallinger S; Haile RW; Hopper JL; Jenkins MA; Lemarchand L; Lindor NM; Newcomb PA; Thibodeau SN; ; Young JP; Buchanan DD; Tavtigian SV; Spurdle AB
Hum Mutat; 2013 Jan; 34(1):200-9. PubMed ID: 22949379
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
